Autocrine VEGF-B signaling maintains lipid synthesis and mitochondrial fitness to support T cell immune responses
Journal of Clinical Investigation · 15.08.2024 · 134 (16)
DOI: 10.1172/jci176586 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.08.2024. Verfasst von Jianli He und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Department of Biochemistry and Molecular Cell Biology. Hauptthemen laut MEDLINE: Mitochondria, Autocrine Communication, T-Lymphocytes, Signal Transduction. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, National Natural Science Foundation of China, Shanghai Jiao Tong University School of Medicine.
Abstract (Originalsprache)
T cells rewire their metabolic activities to meet the demand of immune responses, but how to coordinate the immune response by metabolic regulators in activated T cells is unknown. Here, we identified autocrine VEGF-B as a metabolic regulator to control lipid synthesis and maintain the integrity of the mitochondrial inner membrane for the survival of activated T cells. Disruption of autocrine VEGF-B signaling in T cells reduced cardiolipin mass, resulting in mitochondrial damage, with increased apoptosis and reduced memory development. The addition of cardiolipin or modulating VEGF-B signaling improved T cell mitochondrial fitness and survival. Autocrine VEGF-B signaling through GA-binding protein α (GABPα) induced sentrin/SUMO-specific protease 2 (SENP2) expression, which further de-SUMOylated PPARγ and enhanced phospholipid synthesis, leading to a cardiolipin increase in activated T cells. These data suggest that autocrine VEGF-B mediates a signal to coordinate lipid synthesis and mitochondrial fitness with T cell activation for survival and immune response. Moreover, autocrine VEGF-B signaling in T cells provides a therapeutic target against infection and tumors as well as an avenue for the treatment of autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Department of Biochemistry and Molecular Cell Biology.
- Department of Rheumatology, Renji Hospital.
- Shanghai Institute of Rheumatology, Renji Hospital, and.
- State Key Laboratory of Systems Medicine for Cancer, Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Hainan Medical University, Hainan Academy of Medical Sciences, Haikou, Hainan, China.
Förderung
- the National Key Research and Development Program of China
- National Natural Science Foundation of China
- Shanghai Jiao Tong University School of Medicine
- Shanghai Committee of Science and Technology
Zitieren
APA
He, J., Chen, Y., Ding, H., Zhou, J. A., Xing, Z., Yang, X., Fan, Q., Zuo, Y., Wang, T., & Cheng, J. (2024). Autocrine VEGF-B signaling maintains lipid synthesis and mitochondrial fitness to support T cell immune responses. Journal of Clinical Investigation, 134(16). https://doi.org/10.1172/jci176586
Vancouver
He J, Chen Y, Ding H, Zhou JA, Xing Z, Yang X, et al. Autocrine VEGF-B signaling maintains lipid synthesis and mitochondrial fitness to support T cell immune responses. Journal of Clinical Investigation. 2024;134(16). doi:10.1172/jci176586
BibTeX
@article{He2024,
author = {He, Jianli and Chen, Yalan and Ding, Huihua and Zhou, Jin-An and Xing, Zhengcao and Yang, Xinyu and Fan, Qiuju and Zuo, Yong and Wang, Tianshi and Cheng, Jinke},
title = {Autocrine VEGF-B signaling maintains lipid synthesis and mitochondrial fitness to support T cell immune responses},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {16},
doi = {10.1172/jci176586}
}
EUVIMED